Allergan Aesthetics

BOTOX Cosmetic platysma prominence, OnabotulinumtoxinA Phase 3 study, Platysma muscle activity treatment, BOTOX Cosmetic M21-310 trial, Platysma prominence symptoms, BOTOX Cosmetic neck and jawline, OnabotulinumtoxinA FDA submission,

BOTOX Cosmetic shows promise for neck and lower face rejuvenation in phase 3 trial

Anika Sharma

Allergan Aesthetics, a subsidiary of AbbVie, has unveiled positive top-line findings from the second out of three Phase 3 clinical ...

First-ever JUVÉDERM Day is announced by Allergan Aesthetics

First-ever JUVÉDERM Day is announced by Allergan Aesthetics

SG Tylor

Source – Abbvie That sounds like an exciting announcement! Allergan Aesthetics, now an AbbVie company, is celebrating the first-ever JUVÉDERM ...